Products and Services

ONLY YOU can improve safety.

Verax Platelet PGD®

Verax Platetet PGD® detected bacterial contamination in 1 out of 3,069 culture
negative apheresis units.

Verax Platelet PGD®

The Platelet PGD Test is a rapid, qualitative immunoassay for the detection of aerobic and anaerobic Gram-positive and Gram-negative bacteria in:

  • leukocyte reduced apheresis platelets (LRAP) within 24 hours prior to transfusion of LRAP as a safety measure following testing with a growth-based quality control test cleared by FDA for platelet components and
  • pools of up to six (6) units of leukocyte reduced and non-leukocyte reduced whole blood derived platelets that are pooled within four (4) hours of transfusion as a quality control test

News releases:

FDA Clears Verax Platelet PGD Test as Safety Measure for Platelet Transfusions

Links:

Fenwal Product Catalog
Fenwal Customer Portal (Login Required)
Key features and related products


Click on thumbnail for larger picture
  thumbnail1 thumbnail2 thumbnail3
 

Indication

The Verax Platelet PGD Test has an indication for apheresis platelets - as a day of transfusion safety measure following testing with a growth-based quality control test.

Rapid Test Results

Most test results available in 30 minutes. Tests can be batched together.

Related products

 
Specialty products

Fenwal’s expanding suite of specialty products can help you maximize your efficiency and reduce operational costs today. Specialty Products

Therapeutic Collections

AMICUS Theraputics Leverage the high performance of the Amicus™ Separator for therapeutic collections to help meet current and future demands — safely and simply.

Apheresis Collections

Amicus Our comprehensive portfolio of apheresis collection systems provide high-quality, flexible component collection and processing for your donor centers and mobile drives.